sec filing
IN
NASDAQ · INM
InMed Pharmaceuticals Inc.
Healthcare · Biotechnology
$1.43
Up+$0.02 (+1.44%)
Updated Aug 14, 2026, 2:11 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.52M
- P/E ratio
- -0.17
- Dividend yield
- 0.00%
- 52-week range
- $0.58 – $2.50
- Volume
- 24K
- Avg. volume
- 346.51K
Price performance
INM price history
1M range · 21 trading sessions · Daily adjusted prices
INM closed at $1.43 after 21 trading sessions, down 10.06% for the selected period.
- Last close
- $1.43
- Period change
- -10.06%
- Period low
- $1.40
- Period high
- $1.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $1.45 | $1.458 | $1.4101 | $1.43 | 24K |
| Aug 12, 2026 | $1.45 | $1.48 | $1.41 | $1.44 | 38.62K |
| Aug 11, 2026 | $1.43 | $1.47 | $1.40 | $1.46 | 56.59K |
| Aug 10, 2026 | $1.35 | $1.4996 | $1.35 | $1.41 | 130.84K |
| Aug 7, 2026 | $1.43 | $1.485 | $1.42 | $1.47 | 54.55K |
| Aug 6, 2026 | $1.42 | $1.46 | $1.40 | $1.43 | 43.33K |
| Aug 5, 2026 | $1.48 | $1.50 | $1.40 | $1.40 | 118.41K |
| Aug 4, 2026 | $1.47 | $1.525 | $1.4674 | $1.49 | 71.28K |
| Aug 3, 2026 | $1.47 | $1.50 | $1.4246 | $1.46 | 63.07K |
| Jul 31, 2026 | $1.55 | $1.56 | $1.4404 | $1.47 | 258.49K |
| Jul 30, 2026 | $1.67 | $1.725 | $1.48 | $1.50 | 261.72K |
| Jul 29, 2026 | $1.66 | $1.70 | $1.62 | $1.67 | 223.09K |
| Jul 28, 2026 | $1.62 | $1.725 | $1.61 | $1.67 | 140.46K |
| Jul 27, 2026 | $1.66 | $1.80 | $1.60 | $1.64 | 337.95K |
| Jul 24, 2026 | $1.88 | $1.90 | $1.69 | $1.71 | 332.28K |
| Jul 23, 2026 | $1.65 | $1.95 | $1.60 | $1.85 | 1.32M |
| Jul 22, 2026 | $2.15 | $2.33 | $1.49 | $1.66 | 52.1M |
| Jul 21, 2026 | $1.53 | $1.54 | $1.50 | $1.54 | 10.29K |
| Jul 20, 2026 | $1.56 | $1.56 | $1.49 | $1.52 | 34.43K |
| Jul 17, 2026 | $1.59 | $1.5928 | $1.52 | $1.52 | 12.72K |
| Jul 16, 2026 | $1.5754 | $1.59 | $1.555 | $1.59 | 11.66K |
Latest INM news
The latest Smart Investors Daily articles mentioning INM.
Stock researchResearch & News · SEC Filings
Loading stock research…